Scholarlink

<p>Lymphatic metastasis is a critical determinant of poor prognosis in gastric cancer (GC), yet the underlying regulatory mechanisms remain incompletely understood. While kinesin family member 11 (KIF11) is known to promote lymphangiogenesis, its upstream post-transcriptional regulation in GC has not been elucidated. In this study, we demonstrate for the first time that KIF11 is a direct target of 5-methylcytosine (m<sup>5</sup>C) RNA modification, which is mediated by the methyltransferase NSUN2 and recognized by the m<sup>5</sup>C reader YBX1. Mechanistically, NSUN2 deposits m<sup>5</sup>C marks at specific sites on KIF11 mRNA, particularly at C94413695 and C94413832, which are subsequently recognized by YBX1 to enhance mRNA stability and elevate KIF11 expression. Functionally, upregulated KIF11 promotes lymphangiogenesis by facilitating the Golgi localization and secretion of pro-lymphangiogenic proteins, thereby accelerating lymph node metastasis in GC. These findings uncover a previously unrecognized NSUN2/YBX1–KIF11 regulatory axis and establish m<sup>5</sup>C-dependent post-transcriptional regulation as a key mechanism linking KIF11 upregulation to lymphangiogenesis and metastatic progression in GC. This study provides novel mechanistic insights and identified potential therapeutic targets for the treatment of metastatic GC.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Novel m5C-dependent post-transcriptional regulation of KIF11 drives lymphatic metastasis in gastric cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月29日

查看全文
  • Yi Zhang,
  • Ruofan He,
  • Jianxin Ye,
  • Xiaoxin Xu,
  • Xinyi Gui,
  • Yi Wu,
  • Xinjian Lin,
  • Xu Lin,
  • Kunqi Chen

摘要

Lymphatic metastasis is a critical determinant of poor prognosis in gastric cancer (GC), yet the underlying regulatory mechanisms remain incompletely understood. While kinesin family member 11 (KIF11) is known to promote lymphangiogenesis, its upstream post-transcriptional regulation in GC has not been elucidated. In this study, we demonstrate for the first time that KIF11 is a direct target of 5-methylcytosine (m5C) RNA modification, which is mediated by the methyltransferase NSUN2 and recognized by the m5C reader YBX1. Mechanistically, NSUN2 deposits m5C marks at specific sites on KIF11 mRNA, particularly at C94413695 and C94413832, which are subsequently recognized by YBX1 to enhance mRNA stability and elevate KIF11 expression. Functionally, upregulated KIF11 promotes lymphangiogenesis by facilitating the Golgi localization and secretion of pro-lymphangiogenic proteins, thereby accelerating lymph node metastasis in GC. These findings uncover a previously unrecognized NSUN2/YBX1–KIF11 regulatory axis and establish m5C-dependent post-transcriptional regulation as a key mechanism linking KIF11 upregulation to lymphangiogenesis and metastatic progression in GC. This study provides novel mechanistic insights and identified potential therapeutic targets for the treatment of metastatic GC.